Eckert & Ziegler SE (ETR:EUZ)

Market Cap	914.21M -22.9%
Revenue (ttm)	311.96M +5.4%
Net Income	48.76M +46.5%
EPS	0.78 +46.5%
Shares Out	62.57M
PE Ratio	18.74
Forward PE	17.51
Dividend	0.02 (0.11%)
Ex-Dividend Date	Jun 19, 2025

Volume	210,706
Average Volume	130,131
Open	15.07
Previous Close	15.07
Day's Range	14.24 - 15.07
52-Week Range	13.30 - 23.25
Beta	1.68
RSI	48.65
Earnings Date	Mar 26, 2026

About Eckert & Ziegler SE

Eckert & Ziegler SE manufactures and sells isotope technology components worldwide. It operates through two segments, Medical and Isotope Products. The company provides small implants for the treatment of prostate cancer seeds; and eye applicators based on ruthenium-106 and iodine-125 for the treatment of uveal melanomas; brain seed, HDR and brachytherapy; therapeutic and radiotherapy accessories, X-Ray therapy, GA-68 generators, radiochromatography, hot cells; and radiopharmaceuticals, laboratory equipment, radiosynthesis equipment, quality-co...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1992
• Employees: 1,112
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: EUZ

Financial Performance

In 2025, Eckert & Ziegler SE's revenue was 311.96 million, an increase of 5.45% compared to the previous year's 295.85 million. Earnings were 48.76 million, an increase of 46.54%.